What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey.

Michal ShteinbergJeanette BoydStefano AlibertiEva PolverinoBridget HarrisTove BergAnnette PosthumusThomas RuddyPieter GoeminneErnie LloydTimothy AlanJosje AltenburgBarbara CrossleyFrancesco BlasiJames Chalmers

Published in: ERJ open research (2021)

Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.

Keyphrases

end stage renal disease
healthcare
ejection fraction
chronic kidney disease
mycobacterium tuberculosis
mental health
pulmonary hypertension
peritoneal dialysis
prognostic factors
case report
patient reported outcomes
combination therapy
patient reported